Clinical Trial Update: A Study on the Safety of Hakim Programmable Shunt System

View source ↗

Summary

A completed clinical trial evaluating the safety of the Hakim Programmable Shunt System for hydrocephalus, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hydrocephalus

Drugs mentioned

• Hakim Programmable Shunt System

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Hydrocephalus | Status: COMPLETED | Results posted: 2021-09-21